Clark Wesley has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 162786 shares of ImmunityBio, Inc. ($IBRX) on June 18, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | ImmunityBio, Inc. | $IBRX | Clark Wesley | Director | A | Stock Option (right to buy) | 162786 | $0.00 | 162,786.0000 | 853,556,193 | 9999.99% | 0.02% |
| June 11, 2024 | ImmunityBio, Inc. | $IBRX | Clark Wesley | Director | A | Stock Option (right to buy) | 77633 | $0.00 | 77,633.0000 | 677,003,411 | 9999.99% | 0.01% |
| June 13, 2023 | ImmunityBio, Inc. | $IBRX | Clark Wesley | Director | A | Stock Option (right to buy) | 158263 | $0.00 | 158,263.0000 | 421,569,115 | 9999.99% | 0.04% |
| June 1, 2023 | ImmunityBio, Inc. | $IBRX | Clark Wesley | Director | P | Common Stock | 7000 | $2.91 | 8,000.0000 | 421,569,115 | 700.00% | 0.00% |